{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:16:55Z","timestamp":1787818615934,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A significant proportion of ischemic strokes are classified as embolic stroke of undetermined source (ESUS), complicating secondary prevention. Nitric oxide metabolism is regulated by L-arginine (Arg), asymmetric (ADMA) and symmetric dimethylarginine (SDMA), contributing to increased cardiovascular risk. Previous studies suggest that SDMA and the ratio of Arg\/SDMA help to detect atrial fibrillation (AF). We hypothesized that SDMA and Arg\/SDMA improve diagnosis of cardioembolic stroke (CES), which may enable more accurate secondary prevention. This prospective nested case-control study included ischemic stroke patients (CES or ESUS) at Hannover Medical School between January 2022 and July 2023. Blood samples were collected after 24\u00a0h of stroke onset. ADMA, SDMA and Arg concentrations were measured and relevant biomarker ratios were calculated. Logistic regression and receiver operating curve analyses examined discriminatory biomarker performances for CES versus ESUS, alongside established clinical risk scores. 235 patients (107 CES, 128 ESUS) were analyzed. Arg\/SDMA ratio and SDMA values showed comparable or better discriminatory power between CES and ESUS than clinical AF scores (AUC SDMA\u2009=\u20090.71 (95%CI: 0.64\u20130.77,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001); AUC Arg\/SDMA\u2009=\u20090.74 (95%CI: 0.67\u20130.80,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001)). The same was true for AF detected after stroke (AFDAS) vs. ESUS. When combining Arg\/SDMA-ratio and AS5F, the diagnostic accuracy was modestly improved compared to AS5F alone (DeltaAUC\u2009=\u20090.03 (95%CI: -0.06-0.11)). In conclusion, SDMA and Arg\/SDMA ratio can serve as biomarkers for AF and AFDAS. While the additional predictive value in combination with clinical scores may be limited, these findings support the pathogenic role of the Arg\/SDMA pathway in stroke pathophysiology.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Trial Registration<\/jats:bold>\n                    : The study is retrospectively registered in the German Clinical Trial Register (StudyID DRKS00038459).\n                  <\/jats:p>","DOI":"10.1007\/s12975-026-01460-7","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:50:49Z","timestamp":1784011849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Symmetric Dimethylarginine for Risk Stratification of Cardioembolic Stroke"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5657-4703","authenticated-orcid":false,"given":"Johanna","family":"Ernst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilai Mick Albert Darius","family":"Kaulbarsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja L.","family":"Jochmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Schuppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Lichtinghagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Martens-Lobenhoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelore","family":"Ehrenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie M.","family":"Bode-B\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Grosshennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Weissenborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieke","family":"Ringlstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit M.","family":"Grosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"1460_CR1","doi-asserted-by":"publisher","unstructured":"GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23(10). https:\/\/doi.org\/10.1016\/S1474-4422(24)00369-7.","DOI":"10.1016\/S1474-4422(24)00369-7"},{"key":"1460_CR2","doi-asserted-by":"publisher","unstructured":"Lin B, Zhang Z, Mei Y, Wang C, Xu H, Liu L, Wang W. Cumulative risk of stroke recurrence over the last 10 years: a systematic review and meta-analysis. Neurol Sci: Off J Italian Neurol Soc Italian Soc Clin Neurophysiol. 2021;42(1). https:\/\/doi.org\/10.1007\/s10072-020-04797-5.","DOI":"10.1007\/s10072-020-04797-5"},{"key":"1460_CR3","doi-asserted-by":"publisher","unstructured":"Ornello R, Degan D, Tiseo C, Di Carmine C, Perciballi L, Pistoia F, Carolei A, Sacco S. Distribution and temporal trends from 1993 to 2015 of ischemic stroke subtypes: a systematic review and meta-analysis. Stroke. 2018;49(4). https:\/\/doi.org\/10.1161\/STROKEAHA.117.020031.","DOI":"10.1161\/STROKEAHA.117.020031"},{"key":"1460_CR4","doi-asserted-by":"publisher","unstructured":"Hart RG, Diener H, Coutts SB, Easton JD, Granger CB, O\u2019Donnell MJ, Sacco RL, Connolly SJ. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13(4). https:\/\/doi.org\/10.1016\/S1474-4422(13)70310-7.","DOI":"10.1016\/S1474-4422(13)70310-7"},{"key":"1460_CR5","doi-asserted-by":"publisher","unstructured":"Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, Kreuzer J, Cronin L, Cotton D, Grauer C, et al. Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med. 2019;380(20). https:\/\/doi.org\/10.1056\/NEJMoa1813959.","DOI":"10.1056\/NEJMoa1813959"},{"key":"1460_CR6","doi-asserted-by":"publisher","unstructured":"Hart RG, Sharma M, Mundl H, Kasner SE, Bangdiwala SI, Berkowitz SD, Swaminathan B, Lavados P, Wang Y, Wang Y, et al. Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med. 2018;378(23). https:\/\/doi.org\/10.1056\/NEJMoa1802686.","DOI":"10.1056\/NEJMoa1802686"},{"key":"1460_CR7","doi-asserted-by":"crossref","unstructured":"Geisler T, Keller T, Martus P, Poli K, Serna-Higuita LM, Schreieck J, Gawaz M, T\u00fcnnerhoff J, Bombach P, N\u00e4gele T et al. Apixaban versus aspirin for embolic stroke of undetermined source. NEJM Evid 2023;3(1).","DOI":"10.1056\/EVIDoa2300235"},{"key":"1460_CR8","doi-asserted-by":"publisher","unstructured":"Kamel H, Longstreth WT, Jr, Tirschwell DL, Kronmal RA, Marshall RS, Broderick JP, Arag\u00f3n Garc\u00eda R, Plummer P, Sabagha N, Pauls Q, et al. Apixaban to prevent recurrence after cryptogenic stroke in patients with atrial cardiopathy: the ARCADIA randomized clinical trial. JAMA. 2024;331(7). https:\/\/doi.org\/10.1001\/jama.2023.27188.","DOI":"10.1001\/jama.2023.27188"},{"key":"1460_CR9","doi-asserted-by":"publisher","unstructured":"Grosse GM, Sieweke JT, Biber S, Ziegler NL, Gabriel MM, Schuppner R, Worthmann H, Bavendiek U, Weissenborn K. Nonstenotic carotid plaque in embolic stroke of undetermined source: interplay of arterial and atrial disease. Stroke. 2020;51(12). https:\/\/doi.org\/10.1161\/STROKEAHA.120.030537.","DOI":"10.1161\/STROKEAHA.120.030537"},{"key":"1460_CR10","doi-asserted-by":"publisher","unstructured":"Jochmann SL, Sievering EMW, Ernst J, Ringlstetter R, Grosshennig A, Weissenborn K, Grosse GM. Sex-specific risk factors of nonstenotic carotid plaque in embolic stroke of unknown source: a case-control study. Stroke. 2024;55(2). https:\/\/doi.org\/10.1161\/STROKEAHA.123.044833.","DOI":"10.1161\/STROKEAHA.123.044833"},{"key":"1460_CR11","doi-asserted-by":"publisher","unstructured":"Sieweke J, Biber S, Weissenborn K, Heuschmann PU, Akin M, Zauner F, Gabriel MM, Schuppner R, Berliner D, Bauersachs J, et al. Septal total atrial conduction time for prediction of atrial fibrillation in embolic stroke of unknown source: a pilot study. Clin Res Cardiol. 2020;109(2). https:\/\/doi.org\/10.1007\/s00392-019-01501-2.","DOI":"10.1007\/s00392-019-01501-2"},{"key":"1460_CR12","doi-asserted-by":"publisher","unstructured":"Grosse GM, Biber S, Sieweke J, Martens-Lobenhoffer J, Gabriel MM, Putzer A, Hasse I, van Gemmeren T, Schuppner R, Worthmann H, et al. Plasma dimethylarginine levels and carotid intima\u2013media thickness are related to atrial fibrillation in patients with embolic stroke. Int J Mol Sci. 2019;20(3). https:\/\/doi.org\/10.3390\/ijms20030730.","DOI":"10.3390\/ijms20030730"},{"key":"1460_CR13","doi-asserted-by":"publisher","unstructured":"Grosse GM, Schwedhelm E, Worthmann H, Choe C. Arginine derivatives in cerebrovascular diseases: mechanisms and clinical implications. Int J Mol Sci. 2020;21(5). https:\/\/doi.org\/10.3390\/ijms21051798.","DOI":"10.3390\/ijms21051798"},{"key":"1460_CR14","doi-asserted-by":"publisher","unstructured":"Qin Z, Tang L, Huang Q, Chen Y, Zhong W, Tang X. A systematic review of the correlation between serum asymmetric dimethylarginine, carotid atherosclerosis and ischaemic stroke. Eur J Clin Invest. 2021;51(8). https:\/\/doi.org\/10.1111\/eci.13558.","DOI":"10.1111\/eci.13558"},{"key":"1460_CR15","doi-asserted-by":"publisher","unstructured":"Riddell A, Flynn A, Bergugnat H, Dowsett L, Miller A. SDMA as a marker and mediator in cerebrovascular disease. Clin Sci (Lond). 2024;138(20). https:\/\/doi.org\/10.1042\/CS20241021.","DOI":"10.1042\/CS20241021"},{"key":"1460_CR16","doi-asserted-by":"publisher","unstructured":"Emrich IE, Zawada AM, Martens-Lobenhoffer J, Fliser D, Wagenpfeil S, Heine GH, Bode-B\u00f6ger SM. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease. Clin Res Cardiol. 2018;107(3). https:\/\/doi.org\/10.1007\/s00392-017-1172-4.","DOI":"10.1007\/s00392-017-1172-4"},{"key":"1460_CR17","doi-asserted-by":"publisher","unstructured":"Ziegler NL, Sieweke J, Biber S, Gabriel MM, Schuppner R, Worthmann H, Martens-Lobenhoffer J, Lichtinghagen R, Bode-B\u00f6ger SM, Bavendiek U, et al. Markers of endothelial pathology to support detection of atrial fibrillation in embolic stroke of undetermined source. Sci Rep. 2019;9(1). https:\/\/doi.org\/10.1038\/s41598-019-55943-9.","DOI":"10.1038\/s41598-019-55943-9"},{"key":"1460_CR18","doi-asserted-by":"publisher","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg (London England). 2014;12(12). https:\/\/doi.org\/10.1016\/j.ijsu.2014.07.013.","DOI":"10.1016\/j.ijsu.2014.07.013"},{"key":"1460_CR19","doi-asserted-by":"publisher","unstructured":"Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24(1). https:\/\/doi.org\/10.1161\/01.str.24.1.35.","DOI":"10.1161\/01.str.24.1.35"},{"key":"1460_CR20","doi-asserted-by":"publisher","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R, et al. 2023 ACC\/AHA\/ACCP\/HRS Guideline for the diagnosis and management of atrial fibrillation: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2024;83(1). https:\/\/doi.org\/10.1016\/j.jacc.2023.08.017.","DOI":"10.1016\/j.jacc.2023.08.017"},{"key":"1460_CR21","doi-asserted-by":"publisher","unstructured":"Uphaus T, Weber-Kr\u00fcger M, Grond M, Toenges G, Jahn-Eimermacher A, Jauss M, Kirchhof P, Wachter R, Gr\u00f6schel K. Development and validation of a score to detect paroxysmal atrial fibrillation after stroke. Neurology. 2019;92(2). https:\/\/doi.org\/10.1212\/WNL.0000000000006727.","DOI":"10.1212\/WNL.0000000000006727"},{"key":"1460_CR22","doi-asserted-by":"publisher","unstructured":"Ntaios G, Perlepe K, Lambrou D, Sirimarco G, Strambo D, Eskandari A, Karagkiozi E, Vemmou A, Koroboki E, Manios E, et al. External performance of the HAVOC score for the prediction of new incident atrial fibrillation. Stroke. 2020;51(2). https:\/\/doi.org\/10.1161\/STROKEAHA.119.027990.","DOI":"10.1161\/STROKEAHA.119.027990"},{"key":"1460_CR23","doi-asserted-by":"publisher","unstructured":"Weimar C, Diener HC, Alberts MJ, Steg PG, Bhatt DL, Wilson PW, Mas JL, R\u00f6ther J. The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry. Stroke. 2009;40(2). https:\/\/doi.org\/10.1161\/STROKEAHA.108.521419.","DOI":"10.1161\/STROKEAHA.108.521419"},{"key":"1460_CR24","doi-asserted-by":"publisher","unstructured":"Martens-Lobenhoffer J, Bode-B\u00f6ger SM. Quantification of l-arginine, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma: a step improvement in precision by stable isotope dilution mass spectrometry. J Chromatogr B. 2012;904. https:\/\/doi.org\/10.1016\/j.jchromb.2012.07.021.","DOI":"10.1016\/j.jchromb.2012.07.021"},{"key":"1460_CR25","doi-asserted-by":"publisher","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2021;52(7). https:\/\/doi.org\/10.1161\/STR.0000000000000375.","DOI":"10.1161\/STR.0000000000000375"},{"key":"1460_CR26","doi-asserted-by":"publisher","unstructured":"Ghannam M, Al-Qudah AM, Alshaer QN, Kronmal R, Ntaios G, Childs CA, Longstreth WT, Alsawareah A, Keller T, Serna-Higuita LM, et al. Anticoagulation vs antiplatelets across subgroups of embolic stroke of undetermined source: a meta-analysis of randomized controlled trials. Neurology. 2024;103(9). https:\/\/doi.org\/10.1212\/WNL.0000000000209949.","DOI":"10.1212\/WNL.0000000000209949"},{"key":"1460_CR27","doi-asserted-by":"publisher","unstructured":"Michaud GF, Stevenson WG. Atrial fibrillation. N Engl J Med. 2021;384(4). https:\/\/doi.org\/10.1056\/NEJMcp2023658.","DOI":"10.1056\/NEJMcp2023658"},{"key":"1460_CR28","doi-asserted-by":"publisher","unstructured":"Masood S, Ashraf SMK, Malik MA, Wahab S. P-wave indices and left atrial mechanics as predictors of atrial cardiopathy in embolic stroke of undetermined source. Sci Rep. 2023;13(1). https:\/\/doi.org\/10.1038\/s41598-023-44285-2.","DOI":"10.1038\/s41598-023-44285-2"},{"key":"1460_CR29","doi-asserted-by":"publisher","unstructured":"Sposato LA, Field TS, Schnabel RB, Wachter R, Andrade JG, Hill MD. Towards a new classification of atrial fibrillation detected after a stroke or a transient ischaemic attack. Lancet Neurol. 2024;23(1). https:\/\/doi.org\/10.1016\/S1474-4422(23)00326-5.","DOI":"10.1016\/S1474-4422(23)00326-5"},{"key":"1460_CR30","doi-asserted-by":"publisher","unstructured":"Sposato LA, Chaturvedi S, Hsieh CY, Morillo CA, Kamel H. Atrial fibrillation detected after stroke and transient ischemic attack: a novel clinical concept challenging current views. Stroke. 2022;53(3). https:\/\/doi.org\/10.1161\/STROKEAHA.121.034777.","DOI":"10.1161\/STROKEAHA.121.034777"},{"key":"1460_CR31","doi-asserted-by":"publisher","unstructured":"Yaghi S, Kamel H, Elkind MSV. Atrial cardiopathy: a mechanism of cryptogenic stroke. Expert Rev Cardiovasc Ther. 2017;15(8). https:\/\/doi.org\/10.1080\/14779072.2017.1355238.","DOI":"10.1080\/14779072.2017.1355238"},{"key":"1460_CR32","doi-asserted-by":"publisher","unstructured":"Hannemann J, Wasser K, Mileva Y, Kleinsang F, Schubert M, Schwedhelm E, Guan K, Wachter R, B\u00f6ger R. Symmetric dimethylarginine predicts previously undetected atrial fibrillation in patients with ischemic stroke. J Am Heart Association. 2024;13(17). https:\/\/doi.org\/10.1161\/JAHA.124.034994.","DOI":"10.1161\/JAHA.124.034994"},{"key":"1460_CR33","doi-asserted-by":"publisher","unstructured":"Horowitz JD, De Caterina R, Heresztyn T, Alexander JH, Andersson U, Lopes RD, Steg PG, Hylek EM, Mohan P, Hanna M, et al. Asymmetric and symmetric dimethylarginine predict outcomes in patients with atrial fibrillation: an ARISTOTLE substudy. J Am Coll Cardiol. 2018;72(7). https:\/\/doi.org\/10.1016\/j.jacc.2018.05.058.","DOI":"10.1016\/j.jacc.2018.05.058"},{"key":"1460_CR34","doi-asserted-by":"publisher","unstructured":"Cordts K, Grzybowski R, Lezius S, L\u00fcneburg N, Atzler D, Neu A, Hornig S, B\u00f6ger RH, Gerloff C, Magnus T, et al. Guanidino compound ratios are associated with stroke etiology, internal carotid artery stenosis and CHA2DS2-VASc score in three cross-sectional studies. J Neurol Sci. 2019;397. https:\/\/doi.org\/10.1016\/j.jns.2018.12.037.","DOI":"10.1016\/j.jns.2018.12.037"},{"key":"1460_CR35","doi-asserted-by":"publisher","unstructured":"Atzler D, Gore MO, Ayers CR, Choe CU, B\u00f6ger RH, de Lemos JA, McGuire DK, Schwedhelm E. Homoarginine and cardiovascular outcome in the population-based Dallas heart study. Arterioscler Thromb Vasc Biol. 2014;34(11). https:\/\/doi.org\/10.1161\/ATVBAHA.114.304398","DOI":"10.1161\/ATVBAHA.114.304398"},{"key":"1460_CR36","doi-asserted-by":"publisher","unstructured":"Choe C, Lezius S, Cordts K, Gerloff C, B\u00f6ger RH, Schwedhelm E, Grant PJ. Low homoarginine\/SDMA ratio is associated with poor short- and long-term outcome after stroke in two prospective studies. Neurol Sci. 2020;41(1). https:\/\/doi.org\/10.1007\/s10072-019-04058-0.","DOI":"10.1007\/s10072-019-04058-0"},{"key":"1460_CR37","doi-asserted-by":"publisher","unstructured":"Hanff E, Kayacelebi AA, Yanchev GR, Maassen N, Haghikia A, Tsikas D. Simultaneous stable-isotope dilution GC\u2013MS measurement of homoarginine, guanidinoacetate and their common precursor arginine in plasma and their interrelationships in healthy and diseased humans. Amino Acids. 2016;48(3). https:\/\/doi.org\/10.1007\/s00726-015-2120-0.","DOI":"10.1007\/s00726-015-2120-0"},{"key":"1460_CR38","doi-asserted-by":"publisher","unstructured":"Atzler D, Sch\u00f6nhoff M, Cordts K, Ortland I, Hoppe J, Hummel FC, Gerloff C, Jaehde U, Jagodzinski A, B\u00f6ger RH, et al. Oral supplementation with L-homoarginine in young volunteers. Br J Clin Pharmacol. 2016;82(6). https:\/\/doi.org\/10.1111\/bcp.13068.","DOI":"10.1111\/bcp.13068"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-026-01460-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-026-01460-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-026-01460-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:17:36Z","timestamp":1787815056000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-026-01460-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1460"],"URL":"https:\/\/doi.org\/10.1007\/s12975-026-01460-7","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethics application was approved before the start of the study (Hannover Medical School ethics vote no. 9113_BO_S_2020).","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Each patient must have signed a written consent form if, after receiving thorough information, they agreed to participate in the study. If a patient is unable to give their consent, their legal representative was informed in accordance with the ethics decision and had to sign the consent form if, after receiving thorough information, they agreed to participate in the study.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study reports only anonymized, aggregated data and does not include any individual patient\u00b4s identifiable data.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"79"}}